Cargando...

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high mortality rates. Several clinical trials and meta-analyses have determined that the use of pharmacological inhibitors of cyclooxygenase 2 (COX-2), the enzyme that catalyses the rate-limiting step in the synthe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alicia M. Hidalgo-Estévez, Konstantinos Stamatakis, Marta Jiménez-Martínez, Ricardo López-Pérez, Manuel Fresno
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020-04-01
Colección:Frontiers in Pharmacology
Materias:
Acceso en línea:https://www.frontiersin.org/article/10.3389/fphar.2020.00533/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!